July 07, 2026 08:03 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
China tests ballistic missile from nuclear submarine in Pacific: Australia, New Zealand respond | Baruipur horror: Main accused in alleged rape and murder of minor girl arrested; senior cops dissatisfied with handling of the case | Defence stocks jump after Rs 52,000 crore DAC approval sparks buying frenzy | 'Harry Kane is a great player': Donald Trump after England knocked Mexico out of the World Cup | 'Referee gave a lot against us': Harry Kane reacts after England's dramatic win over Mexico | England hold nerve with 10 men to knock out Mexico in five-goal World Cup classic | 'Why can't citizens protest against the government? They are being made slaves by slapping cases': Bombay HC slams Mumbai Police, quashes activist's externment | 'First he cheats on me...': Siya Goyal's old pub video goes viral amid probe into fiancé Ketan Agarwal's alleged murder | Ronaldo's goal, Ramos' last-gasp winner send Portugal past Croatia, set up Spain clash | India-US trade deal almost done! Piyush Goyal hints at breakthrough
Canada
Pfizer-BioNTech'sCOVID-19 vaccine/Image credit: ContactPharma.com

Health Canada approves use of Pfizer-BioNTech COVID-19 vaccine

| @indiablooms | Dec 11, 2020, at 04:12 am

Canada/IBNS: Health Canada has announced its approval of the use of Pfizer-BioNTech's COVID-19 vaccine in Canada for people over the age of 16 after a two-month review of the company's clinical trial data was completed by the scientists.

Health  Canada is responsible for the country's federal health policy, overseen by the minister of health 

"The data provided support favourably the efficacy of Pfizer-BioNTech COVID-19 vaccine as well as its safety," the department said in its report authorizing the use.

"The efficacy of the vaccine was established to be approximately 95 percent. The vaccine was well tolerated by participants and has no important safety concerns. The benefit-to-risk assessment for Pfizer-BioNTech COVID-19 vaccine is considered favourable."

Canada, the third country in the world to authorize the vaccine, after the United Kingdom and Bahrain, is expected to receive 249,000 doses of the two-dose Pfizer vaccine by year's end,  primarily earmarked for long-term care home residents and the staff working there, said Dr. Howard Njoo, Canada's deputy chief public health officer on Dec 8.

The safety of vaccine use in the United States (US) would be decided on Thursday by the U.S. Food and Drug Administration.

"We expect vaccines to arrive as early as Monday," said Maj.-Gen. Dany Fortin, the military commander leading vaccination logistics at the national operations centre, and added that some Canadians could get their shots by mid-week.

Calling the Pfizer-BioNTech approval a "big deal",  Canada's Prime Minister Justin Trudeau speaking in question period on Dec 8  and added,

"It's a good news day for Canadians but we are not through this yet. We have a tough winter to go through," said Trudeau but urged Canadians to respect public health measures even as shots start to arrive.

The limited initial quantity of about 30,000 expected doses on Monday should be reserved for vulnerable elderly residents of long-term care and assisted living facilities, retirement homes, and chronic care hospitals, and the staff who care for them said the national advisory committee on immunization (NACI) last week.

After their immunization is complete, NACI said the next priority group should be all Canadians over the age of 80. The premiers of the provinces are in agreement, said Trudeau that the NACI guidelines should be followed and the most vulnerable should be first in line.

Trudeau is meeting with premiers virtually on Thursday over vaccine distribution, health care funding, and improving long-term care facilities on the agenda. 

(Reporting by Asha Bajaj)
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.